Medical Device News Magazine

Microban and Cleanwaste Medical Unveil the new Sani-Bag+ with Built-in Antimicrobial Technology

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Microban International is pleased to unveil a new partnership with Cleanwaste Medical to develop the Sani-Bag+ with built-in Microban® antimicrobial product protection. This industry-leading antimicrobial technology helps to protect the commode and bedpan liners from the growth of odor-causing bacteria, and complements Cleanwaste Medical’s proprietary formulation of deodorizing technology and NASA-developed absorbent gel polymer to create waste management solutions that are cleaner and more discreet.

The Sani-Bag+ has been meticulously designed and engineered with Microban technology to address the pressing need for clean and user-friendly disposable commode and bedpan liners in healthcare settings. The addition of innovative Microban® antimicrobial technology sets a new industry standard, further elevating the functionality of these bags to provide a fresher, more comfortable and more dignified experience for the user.

Michael Ruby, President at Microban International, commented:

“Microban is extremely proud of its partnership with Cleanwaste Medical, which brings together the expertise of both companies to deliver a practical and reliable solution for clean waste management. With over 30 years of industry leading experience, Microban’s antimicrobial technologies enhance the cleanliness of these liners by helping to prevent the growth of bacteria, ensuring fresher, cleaner and more convenient solutions for consumers and professionals.”

Sam Alhmad, National Sales Manager at Cleanwaste Medical added:

“We are very excited to partner with a trusted company of Microban’s caliber, and develop a line of antimicrobial Sani-Bag+ products that truly fulfill an unmet need, setting us apart from our competitors. These bags have been carefully designed to deliver a solution with enhanced antimicrobial performance that revolutionizes the user experience and is easily disposed of to prevent contact with waste. Microban® antimicrobial product protection is the perfect addition to these products, marrying up with our proprietary odor-neutralizing and waste absorbance technologies to make these liners the go-to choice for healthcare settings.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”